CLSD - Clearside Biomedical, Inc.
0.41
-0.151 -36.902%
Share volume: 2,599,533
Last Updated: 11-28-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$0.56
-0.15
-0.27%
Summary score
22%
Profitability
25%
Dept financing
13%
Liquidity
49%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-45.68%
Return on assets
-24.21%
Return on sales
0%
Return on invested capital
146.45%
Total debt ratio
39.34%
Debt ratio change over timeo
0%
Current Ratio
6.37%
Quick Ratio
0%
Cash Position Ratio
3.2%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-50.39%
Return on assets
-19.63%
Return on sales
0%
Return on invested capital
51%
Total debt ratio
59.46%
Debt ratio change over timeo
0%
Current Ratio
2%
Quick Ratio
0%
Cash Position Ratio
1.83%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-78.96%
Return on assets
-31.33%
Return on sales
0%
Return on invested capital
74.42%
Total debt ratio
58.92%
Debt ratio change over time
0%
Current Ratio
1.77%
Quick Ratio
0%
Cash Position Ratio
1.64%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CLSD | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -45.68% | 17.45% | 4.69% | -3.05% |
| Return on assets | -24.21% | 3.37% | 3.35% | 3.6% |
| Return on sales | 0% | 23.96% | 25.96% | 32.14% |
| Return on invested capital | 146.45% | 5.2% | 4.37% | 5.09% |
| Profitability | 25% | 68% | 51% | 51% |
| Total debt ratio | 39.34% | 77% | 57.66% | 101.18% |
| Debt ratio change over time | 0% | 0% | 10.55% | 69.81% |
| Dept financing | 10% | 19% | 18% | 50% |
| Current Ratio | 2% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 0% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 1.83% | 0.17% | 0.53% | 1.48% |
| Liquididy | 50% | 27% | 36% | 37% |
| Short-term ratios | CLSD | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -50.39% | 44.06% | 6.24% | -25.62% |
| Return on assets | -19.63% | 3.88% | 3.22% | 3.26% |
| Return on sales | 0% | 27.04% | 24.93% | 31.22% |
| Return on invested capital | 51% | 9.69% | 4.96% | 8.14% |
| Profitability | 25% | 76% | 47% | 50% |
| Total debt ratio | 59.46% | 91.8% | 61.39% | 105.33% |
| Debt ratio change over time | 0% | 0% | 12.93% | 15.97% |
| Dept financing | 14% | 22% | 35% | 50% |
| Current Ratio | 2% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 0% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 1.83% | 0.17% | 0.53% | 1.48% |
| Liquididy | 49% | 28% | 35% | 70% |